These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34927275)

  • 1. Primary age-related tauopathy in a Finnish population-based study of the oldest old (Vantaa 85+).
    Savola S; Kaivola K; Raunio A; Kero M; Mäkelä M; Pärn K; Palta P; Tanskanen M; Tuimala J; Polvikoski T; Tienari PJ; Paetau A; Myllykangas L
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12788. PubMed ID: 34927275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of APOE genotype in primary age-related tauopathy.
    Robinson AC; Davidson YS; Roncaroli F; Minshull J; Tinkler P; Horan MA; Payton A; Pendleton N; Mann DMA
    Acta Neuropathol Commun; 2020 Dec; 8(1):215. PubMed ID: 33287896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.
    Bell WR; An Y; Kageyama Y; English C; Rudow GL; Pletnikova O; Thambisetty M; O'Brien R; Moghekar AR; Albert MS; Rabins PV; Resnick SM; Troncoso JC
    Alzheimers Dement; 2019 Jan; 15(1):8-16. PubMed ID: 30465754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study.
    Hall A; Pekkala T; Polvikoski T; van Gils M; Kivipelto M; Lötjönen J; Mattila J; Kero M; Myllykangas L; Mäkelä M; Oinas M; Paetau A; Soininen H; Tanskanen M; Solomon A
    Alzheimers Res Ther; 2019 Jan; 11(1):11. PubMed ID: 30670070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
    Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
    Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways.
    Hannon E; Shireby GL; Brookes K; Attems J; Sims R; Cairns NJ; Love S; Thomas AJ; Morgan K; Francis PT; Mill J
    Brain Commun; 2020; 2(2):fcaa167. PubMed ID: 33376986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.
    Sabbagh MN; Malek-Ahmadi M; Dugger BN; Lee K; Sue LI; Serrano G; Walker DG; Davis K; Jacobson SA; Beach TG
    BMC Neurol; 2013 May; 13():44. PubMed ID: 23663404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOEε2 is associated with milder clinical and pathological Alzheimer disease.
    Serrano-Pozo A; Qian J; Monsell SE; Betensky RA; Hyman BT
    Ann Neurol; 2015 Jun; 77(6):917-29. PubMed ID: 25623662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
    Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
    JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Effects of NDUFAF6 rs6982393 and APOE on Alzheimer's Disease in Chinese Rural Elderly: A Cross-Sectional Population-Based Study.
    Cheng Y; Li Y; Liang X; Wang P; Fa W; Liu C; Wang Y; Liu K; Wang N; Du Y
    Clin Interv Aging; 2022; 17():185-194. PubMed ID: 35237031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.